Did finally the penny drop?
65% improvement is huge. Imagine what just 30% would mean to a stage 4 patient. So far there are many monoclonal PD1 inhibitors trialed and a few on the market selling for multi billion USD. But almost all come with serious side effects, don't last unless constantly re-administered and have no observed / reported triggered immune system memory effect. From my research only IVX 043 pre-clinical and IMU's CF33 / Her-Vaxx and PD1-Vaxx in clinical trials have ever achieved that.
GLTA
- Forums
- ASX - By Stock
- Ann: INV043 SIGNIFICANTLY IMPROVED CHECKPOINT INHIBITOR THERAPY
Did finally the penny drop? 65% improvement is huge. Imagine...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IVX (ASX) to my watchlist
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.41M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $2.5K | 625K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
27 | 13850565 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 8876035 | 26 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
27 | 13850565 | 0.004 |
23 | 19034337 | 0.003 |
5 | 4900000 | 0.002 |
8 | 13200000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 8876035 | 26 |
0.006 | 3871276 | 12 |
0.007 | 3518975 | 7 |
0.008 | 4842200 | 6 |
0.009 | 2650299 | 8 |
Last trade - 10.04am 25/07/2024 (20 minute delay) ? |
Featured News
IVX (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online